CDR404

· CDR-Life AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CDR404, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors [Phase 1]